Related references
Note: Only part of the references are listed.Cutaneous Metastasis of Micropapillary Urothelial Carcinoma
Hong Truong et al.
UROLOGY (2015)
Comparative Effectiveness of Oral Drug Therapies for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis
Xinghuan Wang et al.
PLOS ONE (2014)
The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
Francois Giuliano et al.
EUROPEAN UROLOGY (2013)
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Matthias Oelke et al.
EUROPEAN UROLOGY (2013)
Direct androgen regulation of PDE5 gene or the lack thereof
C-S Lin et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2013)
Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling
Xinhua Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats
Mee-Young Lee et al.
ASIAN JOURNAL OF ANDROLOGY (2012)
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer
Tim M. van der Sluis et al.
BJU INTERNATIONAL (2012)
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Kevin T. McVary et al.
JOURNAL OF UROLOGY (2011)
Estrogen and androgen signaling in the pathogenesis of BPH
Clement K. M. Ho et al.
NATURE REVIEWS UROLOGY (2011)
Beta-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of α1A-adrenoceptors
Martin Hennenberg et al.
WORLD JOURNAL OF UROLOGY (2011)
Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
Benedetta Fibbi et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Lack of direct androgen regulation of PDE5 expression
Rong Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Prostate Growth Inhibition by Subtype-Selective Alpha1-Adrenoceptor Antagonist Naftopidil in Benign Prostatic Hyperplasia
Yoshiyuki Kojima et al.
PROSTATE (2009)
Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue
Stefan Ueckert et al.
UROLOGY (2008)
Characterization and functional role of androgen-dependent PDE5 activity in the bladder
Sandra Filippi et al.
ENDOCRINOLOGY (2007)
Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate
S Ückert et al.
EUROPEAN UROLOGY (2006)
Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum
XH Zhang et al.
EUROPEAN UROLOGY (2005)
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens
R Mancina et al.
MOLECULAR HUMAN REPRODUCTION (2005)
α1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia
CG Roehrborn et al.
JOURNAL OF UROLOGY (2004)
Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa
A Morelli et al.
ENDOCRINOLOGY (2004)
Sildenafil influences lower urinary tract symptoms
K Sairam et al.
BJU INTERNATIONAL (2002)
Modulation of bladder alpha 1-adrenergic receptor subtype expression by bladder outlet obstruction
C Hampel et al.
JOURNAL OF UROLOGY (2002)
Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate
S Ückert et al.
JOURNAL OF UROLOGY (2001)
Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways
R Kühn et al.
UROLOGICAL RESEARCH (2000)
Share Paper
